NewEdge Advisors’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Buy
13,027
+796
+7% +$65.3K ﹤0.01% 1457
2025
Q4
$1.12M Sell
12,231
-370
-3% -$35.4K ﹤0.01% 1414
2025
Q3
$1.19M Buy
12,601
+920
+8% +$86.6K 0.01% 1294
2025
Q2
$1.22M Sell
11,681
-941
-7% -$89.2K 0.01% 1180
2025
Q1
$1.12M Sell
12,622
-361
-3% -$37K 0.01% 1124
2024
Q4
$1.25M Buy
12,983
+384
+3% +$35.8K 0.01% 1054
2024
Q3
$1.03M Buy
12,599
+1,347
+12% +$104K 0.01% 1091
2024
Q2
$970K Sell
11,252
-3,076
-21% -$249K 0.01% 1085
2024
Q1
$1.17M Sell
14,328
-1,202
-8% -$93.9K 0.01% 927
2023
Q4
$1.08M Buy
15,530
+4,024
+35% +$279K 0.01% 898
2023
Q3
$841K Sell
11,506
-1,792
-13% -$121K 0.01% 939
2023
Q2
$840K Buy
13,298
+332
+3% +$19.3K 0.01% 951
2023
Q1
$761K Sell
12,966
-1,543
-11% -$93.7K 0.01% 910
2022
Q4
$132K Buy
14,509
+1,985
+16% +$133K ﹤0.01% 1334
2022
Q3
$841K Buy
+12,524
New +$793K 0.01% 717

Other funds holding HQY

NewEdge Advisors's HQY Position: Q1 2026 in Review

NewEdge Advisors increased its HealthEquity (HQY) stake by 6.5% in Q1 2026, buying an estimated $65.3K and bringing the position to 13,027 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1457.

NewEdge Advisors first reported a position in HQY in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.25M in Q4 2024. 485 funds tracked by Wall St. Rank hold HQY as of Q1 2026.

  • NewEdge Advisors held 13,027 shares of HealthEquity worth $1.09M as of Q1 2026.
  • NewEdge Advisors bought 796 HealthEquity shares in Q1 2026, an estimated $65.3K.
  • HealthEquity made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #1457 holding.
  • NewEdge Advisors first reported a position in HealthEquity in Q3 2022 and has held it in 15 quarters since.
  • NewEdge Advisors's HealthEquity position peaked at $1.25M in Q4 2024.
  • 485 funds tracked by Wall St. Rank held HealthEquity as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.